MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹333 Cr | ₹241 Cr | ₹290 Cr | ₹167 Cr | ₹138 Cr |
What is the latest Total Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹290 Cr |
| Mar2022 | ₹167 Cr |
| Mar2021 | ₹138 Cr |
How is Total Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹333 Cr | 38.03 | |
| Mar2024 | ₹241 Cr | -16.89 | |
| Mar2023 | ₹290 Cr | 74.27 | |
| Mar2022 | ₹167 Cr | 20.76 | |
| Mar2021 | ₹138 Cr | - | |
Compare Total Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹387.3 Cr | -1.3% | -16% | -2.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,374.0 Cr | 5.8% | -5.4% | -17% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,591.5 Cr | 0.6% | -6.9% | 4.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,211.6 Cr | 3.8% | -0.5% | -13.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹945.0 Cr | 1.5% | -13.8% | -40.1% | Stock Analytics | |
| INDO US BIOTECH | ₹251.9 Cr | 4.6% | 4.2% | -40.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -1.3% |
-16% |
-2.7% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses